Year To Quarter End Statement Of Income

PhoenixBio Co.,Ltd. - Filing #7297348

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Year to quarter end statement of income
Statement of income
Net sales
788,201,000 JPY
881,757,000 JPY
Cost of sales
240,469,000 JPY
311,040,000 JPY
Gross profit (loss)
547,731,000 JPY
570,716,000 JPY
Selling, general and administrative expenses
646,561,000 JPY
575,801,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
75,793,000 JPY
78,622,000 JPY
Depreciation
4,039,000 JPY
4,111,000 JPY
Operating profit (loss)
-98,830,000 JPY
-5,084,000 JPY
Non-operating income
Interest income
3,778,000 JPY
2,743,000 JPY
Non-operating income
4,858,000 JPY
52,158,000 JPY
Non-operating expenses
Interest expenses
2,599,000 JPY
972,000 JPY
Non-operating expenses
29,680,000 JPY
1,205,000 JPY
Ordinary profit (loss)
-123,652,000 JPY
45,868,000 JPY
Extraordinary income
Extraordinary income
JPY
17,285,000 JPY
Extraordinary losses
Extraordinary losses
0 JPY
JPY
Profit (loss) before income taxes
-123,652,000 JPY
63,154,000 JPY
Income taxes - current
4,077,000 JPY
4,818,000 JPY
Income taxes - deferred
-2,980,000 JPY
30,708,000 JPY
Income taxes
1,096,000 JPY
35,527,000 JPY
Profit (loss)
-124,748,000 JPY
27,626,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.